Similarly, for prostate cancer, KDM1A [55], BRD4 [56], and PRMT1 [57] were depleted in LNCaP cells as well as AR, FOXA1 and NCOA1 [58, 59], thus serving as positive controls. This evidence concerns the gene BRD4 and prostate carcinoma.